CYCLIC ADP RIBOSE METABOLISM IN OXIDATIVE CELL DEATH
氧化性细胞死亡中的循环 ADP 核糖代谢
基本信息
- 批准号:6479399
- 负责人:
- 金额:$ 16.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-05-01 至 2003-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from applicant's abstract): Oxidative stress, defined as
an abnormal accumulation of reactive oxygen species (ROS), disrupts normal cell
signaling pathways often resulting in cell death by apoptosis or necrosis.
Calcium signaling is involved in pathways leading to oxidant induced cell
death. In preliminary experiments, the investigator and his associates show
that oxidant induced apoptosis results in a marked elevation of cyclic
adenosine diphosphoribose (cADPR), which is a metabolite of NAD that elicits
calcium mobilization. The elevation of cADPR is due to activation of a membrane
cADPR synthase, linked to the activation of the mitochondrial permeability
transition (PT), and causally related to increases in levels of intracellular
free calcium. These data have led to the investigator's hypothesis, that cADPR
functions in a signaling pathway that is activated by oxidant stress and leads
to disruption of calcium homeostasis and to oxidant induced cell death. He will
test this hypothesis in PC12 cells, which are widely used as a model system of
neuronal cell death relating to oxidant toxicity. Studies will be conducted in
PC12 cells overexpressing Bcl-2, a potent inhibitor of the mitochondrial PT and
apoptosis, and in a control cell line containing only vector, to allow
segregation of events upstream and downstream from the effector phase of
apoptosis. The first specific aim is to identify the cADPR synthase(s)
activated by oxidant stress. A molecular genetic approach will be used to
determine if the target enzyme is one of two known cADPR synthases (CD38 or
BST-l) or a novel enzyme. According to the investigator, identification of the
synthase is a prerequisite to studies of the mechanism of oxidant induced
activation of cADPR and evaluation of the therapeutic potential of this
metabolism.
The second specific aim will establish whether cADPR formation is obligatory in
oxidant induced apoptosis and will identify specific functions of cADPR in cell
death. PC12 cells will be stably transfected with inducible sense and antisense
cDNA constructs encoding the cADPR synthase activated by oxidant stress. Enzyme
depletion and overexpression will then be used to assess the role of cADPR
synthase in the cell death pathway, as monitored by examination of specific
biochemical markers of apoptosis. The third specific aim will determine if
cADPR synthase activation is involved in initiating pathways of apoptosis
specific to ROS, or whether it results from ROS generated in the effector phase
of apoptosis. Initiators will include tumor necrosis factor alpha (TNF-(),
anti-Fas antibodies, N-methyl-N'-nitro-N-nitrosoguanidine (MNNG),
Staurosporine, and serum withdrawal. The studies are designed to advance our
understanding of mechanisms of cell death and provide potentially new targets
for reduction of oxidant induced cell death that results from re-perfusion
injury following vascular or cerebral ischemia.
描述(改编自申请人的摘要):氧化应激,定义为
活性氧 (ROS) 的异常积累会破坏正常细胞
信号通路通常导致细胞凋亡或坏死。
钙信号传导参与导致氧化诱导细胞的途径
死亡。在初步实验中,研究人员和他的同事表明
氧化剂诱导的细胞凋亡导致循环周期显着升高
腺苷二磷酸核糖 (cADPR),它是 NAD 的代谢产物,可引起
钙动员。 cADPR 的升高是由于膜的激活
cADPR 合酶,与线粒体通透性的激活有关
转变(PT),并且与细胞内水平的增加有因果关系
游离钙。这些数据导致了研究者的假设,即 cADPR
在氧化应激激活的信号通路中发挥作用并导致
钙稳态的破坏和氧化剂诱导的细胞死亡。他会
在 PC12 细胞中检验这一假设,PC12 细胞被广泛用作
与氧化剂毒性有关的神经元细胞死亡。研究将在
PC12 细胞过表达 Bcl-2(线粒体 PT 的有效抑制剂)
细胞凋亡,并且在仅含有载体的对照细胞系中,允许
效应器阶段上游和下游事件的分离
细胞凋亡。第一个具体目标是鉴定 cADPR 合酶
被氧化应激激活。分子遗传学方法将用于
确定目标酶是否是两种已知的 cADPR 合酶(CD38 或
BST-1)或一种新型酶。据调查人员称,经鉴定,
合酶是研究氧化诱导机制的先决条件
cADPR 的激活并评估其治疗潜力
代谢。
第二个具体目标将确定 cADPR 的形成是否是强制性的
氧化剂诱导细胞凋亡,并鉴定细胞中 cADPR 的特定功能
死亡。 PC12细胞将被诱导有义和反义稳定转染
编码由氧化应激激活的 cADPR 合酶的 cDNA 构建体。酶
然后,耗尽和过度表达将用于评估 cADPR 的作用
细胞死亡途径中的合酶,通过检查特定的
细胞凋亡的生化标志物。第三个具体目标将决定是否
cADPR 合酶激活参与细胞凋亡的启动途径
特定于 ROS,或者是否是效应器阶段生成的 ROS 的结果
细胞凋亡。引发剂将包括肿瘤坏死因子α(TNF-()、
抗 Fas 抗体、N-甲基-N'-硝基-N-亚硝基胍 (MNNG)、
星形孢菌素和血清戒断。这些研究旨在推进我们的
了解细胞死亡机制并提供潜在的新靶标
减少再灌注导致的氧化剂诱导的细胞死亡
血管或脑缺血后的损伤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MYRON K JACOBSON其他文献
MYRON K JACOBSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MYRON K JACOBSON', 18)}}的其他基金
CYCLIC ADP RIBOSE METABOLISM IN OXIDATIVE CELL DEATH
氧化性细胞死亡中的循环 ADP 核糖代谢
- 批准号:
2830719 - 财政年份:1999
- 资助金额:
$ 16.58万 - 项目类别:
CYCLIC ADP RIBOSE METABOLISM IN OXIDATIVE CELL DEATH
氧化性细胞死亡中的循环 ADP 核糖代谢
- 批准号:
6540072 - 财政年份:1999
- 资助金额:
$ 16.58万 - 项目类别:
CYCLIC ADP RIBOSE METABOLISM IN OXIDATIVE CELL DEATH
氧化性细胞死亡中的循环 ADP 核糖代谢
- 批准号:
6351880 - 财政年份:1999
- 资助金额:
$ 16.58万 - 项目类别:
CYCLIC ADP RIBOSE METABOLISM IN OXIDATIVE CELL DEATH
氧化性细胞死亡中的循环 ADP 核糖代谢
- 批准号:
6151630 - 财政年份:1999
- 资助金额:
$ 16.58万 - 项目类别:
NIACIN NUTRITION, ADP-RIBOSYLATION AND CANCER SYMPOSIUM
烟酸营养、ADP-核糖化与癌症研讨会
- 批准号:
3433936 - 财政年份:1987
- 资助金额:
$ 16.58万 - 项目类别:
ALTERATION OF NAD METABOLISM BY CHEMICAL CARCINOGENS
化学致癌物改变 NAD 代谢
- 批准号:
3186350 - 财政年份:1986
- 资助金额:
$ 16.58万 - 项目类别:
ALTERATION OF NAD METABOLISM BY CHEMICAL CARCINOGENS
化学致癌物改变 NAD 代谢
- 批准号:
3186346 - 财政年份:1986
- 资助金额:
$ 16.58万 - 项目类别:
相似国自然基金
远距离调控元件mbr对BCL2基因启动子表观遗传信息调控作用机制的研究
- 批准号:90919051
- 批准年份:2009
- 资助金额:60.0 万元
- 项目类别:重大研究计划
相似海外基金
Functional role of Sec20, a BH3 and Secretory (Sec) domain protein, in neurons and its relevance to a motor neuron disease in Drosophila
Sec20(一种 BH3 和分泌 (Sec) 结构域蛋白)在神经元中的功能作用及其与果蝇运动神经元疾病的相关性
- 批准号:
10635856 - 财政年份:2023
- 资助金额:
$ 16.58万 - 项目类别:
Role of necroptosis in colorectal cancer therapy
坏死性凋亡在结直肠癌治疗中的作用
- 批准号:
10891823 - 财政年份:2023
- 资助金额:
$ 16.58万 - 项目类别:
Effector-triggered immunity against Legionella pneumophila in dendritic cells
树突状细胞中针对嗜肺军团菌的效应子触发免疫
- 批准号:
10753211 - 财政年份:2023
- 资助金额:
$ 16.58万 - 项目类别:
Understanding resistance mechanisms to protein arginine methyltransransferase Inhibitors in Lymphoma
了解淋巴瘤对蛋白精氨酸甲基转移酶抑制剂的耐药机制
- 批准号:
10668754 - 财政年份:2023
- 资助金额:
$ 16.58万 - 项目类别:
Targeting the BCL2 immune checkpoint to enhance the immunostimulatory effects of radiation in breast cancer
靶向 BCL2 免疫检查点增强放射对乳腺癌的免疫刺激作用
- 批准号:
10734237 - 财政年份:2023
- 资助金额:
$ 16.58万 - 项目类别: